the present invention solves these problems by providing BPC peptide salts and a pharmaceutical or diagnostic composition comprising a pharmaceutically or diagnostically effective amount of the salts of BPC peptides said peptides being constituted of 8 to 15 amino acids, wherein the anion of the salt is a negatively charged peptide comprising 8 amino acid residues having the general formula (I) wherein Xaa is a neutral aliphatic amino acid residue, in particular Ala, bAla, Leu, Ile, Gly, Val, Nle or Nva, Yaa is a basic amino acid residue, in particular Lys, Arg, Orn or His and Zaa is an acidic amino acid residue, in particular Glu, Asp, Aad or Apm and wherein the cation of the salt is the cation of an inorganic or organic nontoxic and pharmaceutically acceptable base
How are GLP-1 drugs used for weight loss
Research on both mice and humans has highlighted the essential role of IL-33 in stimulating ILC2s and Th2 cells to secrete type 2 cytokines, such as IL-5 and IL-13, which trigger allergic responses driven by the innate immune system [178,179,180]
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test can help provide context for GLP-1 pathway function by revealing predispositions in key variants (GIPR, FTO, MC4R) linked to weight regulation and insulin sensitivity
Decreased Stroke Risk: Users have experienced a 7% reduction in stroke risk
